Literature DB >> 29619815

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.

Ignace Vergote1, Luis Chiva2, Andreas du Bois3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29619815     DOI： 10.1056/NEJMc1802033

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

Review 2.  Hyperthermic Intraperitoneal Chemotherapy in the Treatment Armamentarium of Epithelial Ovarian Cancer: Time to End the Dichotomy.

Authors:  Aditi Bhatt; Olivier Glehen
Journal:  Visc Med       Date:  2022-01-10

3.  A Retrospective Clinical Analysis of Hyperthermic Intraperitoneal Chemotherapy in Gynecological Cancers: Technical Details, Tolerability, and Efficacy.

Authors:  Yagmur Minareci; Ozgur Aydın Tosun; Hamdullah Sozen; Samet Topuz; Mehmet Yavuz Salihoglu
Journal:  Medeni Med J       Date:  2020-09-30

4.  Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: A systematic review and meta-analysis.

Authors:  Se Ik Kim; Jaehyun Cho; Eun Ji Lee; Sunwoo Park; Soo Jin Park; Aeran Seol; Nara Lee; Ga Won Yim; Maria Lee; Whasun Lim; Gwonhwa Song; Suk Joon Chang; Jae Won Kim; Hee Seung Kim
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

Review 5.  Hyperthermic intraperitoneal chemotherapy in ovarian cancer: Qui Bono?

Authors:  John Spiliotis
Journal:  Ann Transl Med       Date:  2020-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.